Myriad Genetics | MYGN - Market Capitalization


Myriad Genetics reported $488M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 32.66B 5.2B Mar/2026
Becton, Dickinson and Co. USD 44.77B 10.52B Mar/2026
Bruker USD 5.5B 1.66B Mar/2026
Danaher USD 128.46B 33.24B Mar/2026
Illumina USD 17.88B 2.74B Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Mettler Toledo International USD 25.54B 2.94B Mar/2026
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Quest Diagnostics USD 21.69B 2.39B Mar/2026
Quidel USD 1.01B 984M Mar/2026
Repligen USD 6.64B 2.58B Mar/2026
Revvity USD 9.94B 1.03B Mar/2026
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
Veracyte USD 2.57B 758M Mar/2026
Waters USD 29.87B 7.25B Mar/2026